FR3046934B1 - Souche de faecalibacterium prausnitzii cncm i-4573 pour le traitement et la prevention d'une inflammation gastro-intestinale - Google Patents

Souche de faecalibacterium prausnitzii cncm i-4573 pour le traitement et la prevention d'une inflammation gastro-intestinale Download PDF

Info

Publication number
FR3046934B1
FR3046934B1 FR1650567A FR1650567A FR3046934B1 FR 3046934 B1 FR3046934 B1 FR 3046934B1 FR 1650567 A FR1650567 A FR 1650567A FR 1650567 A FR1650567 A FR 1650567A FR 3046934 B1 FR3046934 B1 FR 3046934B1
Authority
FR
France
Prior art keywords
prevention
treatment
faecalibacterium prausnitzii
gastrointestinal inflammation
strain cncm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1650567A
Other languages
English (en)
French (fr)
Other versions
FR3046934A1 (fr
Inventor
Philippe Langella
Rebeca Martin Rosique
Luis Bermudez Humaran
Florian CHAIN
Harry SOKOL
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite Pierre et Marie Curie
Assistance Publique Hopitaux de Paris APHP
Institut National de Recherche pour lAgriculture lAlimentation et lEnvironnement
Original Assignee
Universite Pierre et Marie Curie
Assistance Publique Hopitaux de Paris APHP
Institut National de la Recherche Agronomique INRA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR1650567A priority Critical patent/FR3046934B1/fr
Application filed by Universite Pierre et Marie Curie, Assistance Publique Hopitaux de Paris APHP, Institut National de la Recherche Agronomique INRA filed Critical Universite Pierre et Marie Curie
Priority to HUE17702322A priority patent/HUE050810T2/hu
Priority to CA3012214A priority patent/CA3012214C/fr
Priority to EP17702322.3A priority patent/EP3407902B1/fr
Priority to PT177023223T priority patent/PT3407902T/pt
Priority to US16/072,319 priority patent/US10918678B2/en
Priority to PL17702322T priority patent/PL3407902T3/pl
Priority to PCT/EP2017/051306 priority patent/WO2017129515A1/fr
Priority to NZ744528A priority patent/NZ744528A/en
Priority to BR112018015121-1A priority patent/BR112018015121B1/pt
Priority to SG11201806361PA priority patent/SG11201806361PA/en
Priority to JP2018557200A priority patent/JP6935632B2/ja
Priority to CN201780019735.0A priority patent/CN109310714A/zh
Priority to AU2017211244A priority patent/AU2017211244B2/en
Priority to LTEP17702322.3T priority patent/LT3407902T/lt
Priority to ES17702322T priority patent/ES2820338T3/es
Publication of FR3046934A1 publication Critical patent/FR3046934A1/fr
Application granted granted Critical
Publication of FR3046934B1 publication Critical patent/FR3046934B1/fr
Priority to IL260752A priority patent/IL260752B/en
Priority to ZA201805302A priority patent/ZA201805302B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
FR1650567A 2016-01-25 2016-01-25 Souche de faecalibacterium prausnitzii cncm i-4573 pour le traitement et la prevention d'une inflammation gastro-intestinale Active FR3046934B1 (fr)

Priority Applications (18)

Application Number Priority Date Filing Date Title
FR1650567A FR3046934B1 (fr) 2016-01-25 2016-01-25 Souche de faecalibacterium prausnitzii cncm i-4573 pour le traitement et la prevention d'une inflammation gastro-intestinale
JP2018557200A JP6935632B2 (ja) 2016-01-25 2017-01-23 胃腸炎の処置及び予防のためのフィーカリバクテリウム・プラウスニッツィｃｎｃｍ ｉ−４５７３株
EP17702322.3A EP3407902B1 (fr) 2016-01-25 2017-01-23 Souche de faecalibacterium prausnitzii cncm 1-4573 pour le traitement et la prevention d'une inflammation gastro-intestinale
PT177023223T PT3407902T (pt) 2016-01-25 2017-01-23 Estirpe cncm i-4573 de faecalibacterium prausnitzii para o tratamento e a prevenção de inflamação gastrointestinal
US16/072,319 US10918678B2 (en) 2016-01-25 2017-01-23 Faecalibacterium prausnitzii strain CNCM 1-4573 for the treatment and prevention of gastrointestinal inflammation
PL17702322T PL3407902T3 (pl) 2016-01-25 2017-01-23 Szczep faecalibacterium prausnitzii cncm 1-4573 w leczeniu i zapobieganiu zapalenia przewodu pokarmowego
PCT/EP2017/051306 WO2017129515A1 (fr) 2016-01-25 2017-01-23 Souche de faecalibacterium prausnitzii cncm 1-4573 pour le traitement et la prevention d'une inflammation gastro-intestinale
NZ744528A NZ744528A (en) 2016-01-25 2017-01-23 Faecalibacterium prausnitzii strain cncm i-4573 for the treatment and prevention of gastrointestinal inflammation
BR112018015121-1A BR112018015121B1 (pt) 2016-01-25 2017-01-23 Cepa bacteriana da espécie faecalibacterium prausnitzii cncm i-4573 para o tratamento e a prevenção da inflamação gastrointestinal
AU2017211244A AU2017211244B2 (en) 2016-01-25 2017-01-23 Faecalibacterium prausnitzii strain CNCM 1-4573 for the treatment and prevention of gastrointestinal inflammation
HUE17702322A HUE050810T2 (hu) 2016-01-25 2017-01-23 Faecalibacterium prausnitzii CNCM 1-4573 törzse gyomor-bélrendszeri gyulladás kezelésére és megelõzésére
CA3012214A CA3012214C (fr) 2016-01-25 2017-01-23 Souche de faecalibacterium prausnitzii cncm i-4573 pour le traitement et la prevention d'une inflammation gastro-intestinale
SG11201806361PA SG11201806361PA (en) 2016-01-25 2017-01-23 Faecalibacterium prausnitzii strain cncm 1-4573 for the treatment and prevention of gastrointestinal inflammation
LTEP17702322.3T LT3407902T (lt) 2016-01-25 2017-01-23 Faecalibacterium prausnitzii kamienas cncm 1-4573, skirtas virškinamojo trakto uždegimo gydymui ir prevencijai
ES17702322T ES2820338T3 (es) 2016-01-25 2017-01-23 Cepa de Faecaslibacterium Prausnitzii CNCM I-4573 para el tratamiento y la prevención de una inflamación gastrointestinal
CN201780019735.0A CN109310714A (zh) 2016-01-25 2017-01-23 用于治疗和预防胃肠炎症的普氏粪杆菌菌株cncm i-4573
IL260752A IL260752B (en) 2016-01-25 2018-07-24 Faecalibacterium prausnitzii strain cncm 1-4573 for the treatment and prevention of gastrointestinal inflammation
ZA201805302A ZA201805302B (en) 2016-01-25 2018-08-10 Faecalibacterium prausnitzii strain cncm 1-4573 for the treatment and prevention of gastrointestinal inflammation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1650567 2016-01-25
FR1650567A FR3046934B1 (fr) 2016-01-25 2016-01-25 Souche de faecalibacterium prausnitzii cncm i-4573 pour le traitement et la prevention d'une inflammation gastro-intestinale

Publications (2)

Publication Number Publication Date
FR3046934A1 FR3046934A1 (fr) 2017-07-28
FR3046934B1 true FR3046934B1 (fr) 2018-01-26

Family

ID=55862967

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1650567A Active FR3046934B1 (fr) 2016-01-25 2016-01-25 Souche de faecalibacterium prausnitzii cncm i-4573 pour le traitement et la prevention d'une inflammation gastro-intestinale

Country Status (17)

Country Link
US (1) US10918678B2 (enExample)
EP (1) EP3407902B1 (enExample)
JP (1) JP6935632B2 (enExample)
CN (1) CN109310714A (enExample)
AU (1) AU2017211244B2 (enExample)
CA (1) CA3012214C (enExample)
ES (1) ES2820338T3 (enExample)
FR (1) FR3046934B1 (enExample)
HU (1) HUE050810T2 (enExample)
IL (1) IL260752B (enExample)
LT (1) LT3407902T (enExample)
NZ (1) NZ744528A (enExample)
PL (1) PL3407902T3 (enExample)
PT (1) PT3407902T (enExample)
SG (1) SG11201806361PA (enExample)
WO (1) WO2017129515A1 (enExample)
ZA (1) ZA201805302B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10010412B2 (en) * 2011-07-27 2018-07-03 Edwards Lifesciences Corporation Conical crimper
TWI778083B (zh) * 2017-06-16 2022-09-21 日商表飛鳴製藥股份有限公司 脂肪關連疾患及/或炎症的預防或治療劑
FR3084255B1 (fr) * 2018-07-26 2020-07-03 Institut National De La Recherche Agronomique (Inra) Souche de streptococcus thermophilus cnrz160 pour le traitement et la prevention de l'inflammation intestinale et des desordres associes, chez un individu
FR3099053B1 (fr) * 2019-07-24 2023-01-20 Inst Nat De La Rech Agronomique Inra Souches bacteriennes pour le traitement et la prevention d’une inflammation gastro-intestinale
EP3838276A1 (en) 2019-12-17 2021-06-23 Exeliom Biosciences Association of faecalibacterium prausnitzii strain cncm i-4573 with pentasa® for the treatment and prevention of gastrointestinal inflammation
KR102169795B1 (ko) * 2020-06-24 2020-10-27 주식회사 엔테로바이옴 신규한 피칼리박테리움 프로스니치 eb-fpdk9 균주 및 그의 용도
KR102169794B1 (ko) * 2020-06-24 2020-10-27 주식회사 엔테로바이옴 신규한 피칼리박테리움 프로스니치 균주 eb-fpdk11 및 그의 용도
EP4180051A4 (en) * 2020-07-13 2024-07-17 Ajou University Industry-Academic Cooperation Foundation Composition for preventing or treating inflammatory bowel disease
JP7535174B2 (ja) * 2020-08-14 2024-08-15 コバイオラブス，インコーポレーテッド フィーカリバクテリウムプラウスニッツィ菌株およびその用途
JP7570506B2 (ja) * 2020-09-28 2024-10-21 シージェイ バイオサイエンス， インク． 微生物を含む炎症性疾患の診断または治療用組成物
CN112402459B (zh) * 2020-10-27 2023-01-31 江南大学 普拉梭菌缓解过敏性哮喘和鼻炎Th2反应中的应用
KR102245415B1 (ko) * 2020-12-14 2021-04-29 주식회사 엔테로바이옴 피칼리박테리움 프로스니치 균주 배양 배지 조성물
EP4166150A1 (en) 2021-10-15 2023-04-19 Exeliom Biosciences Association of a faecalibacterium prausnitzii strain and anti-pd-1, anti-pd-l1 or anti-ctla-4 antibodies for the treatment of cancer
EP4389134A1 (en) * 2022-12-20 2024-06-26 Exeliom Biosciences Faecalibacterium prausnitzii strain cncm i-4573 for the treatment and prevention of clostridioides difficile infection
CN118845848B (zh) * 2024-07-01 2025-10-17 温州大学 普氏粪杆菌dsm 17677在制备防治猪流行性腹泻病毒感染产品中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2015011700A (es) * 2013-03-05 2016-07-20 Univ Groningen Uso de la bacteria faecalibacterium prausnitzii htf-f (dsm 26943) para suprimir la inflamacion.
WO2016075294A1 (en) * 2014-11-13 2016-05-19 Institut National De La Recherche Agronomique (Inra) Faecalibacterium prausnitzii strains for treating and preventing gastrointestinal pain

Also Published As

Publication number Publication date
JP2019508486A (ja) 2019-03-28
AU2017211244A1 (en) 2018-08-09
US20190030089A1 (en) 2019-01-31
NZ744528A (en) 2020-02-28
EP3407902B1 (fr) 2020-07-15
CN109310714A (zh) 2019-02-05
CA3012214C (fr) 2024-09-17
ZA201805302B (en) 2019-10-30
IL260752B (en) 2021-02-28
FR3046934A1 (fr) 2017-07-28
WO2017129515A1 (fr) 2017-08-03
CA3012214A1 (fr) 2017-08-03
PT3407902T (pt) 2020-09-03
PL3407902T3 (pl) 2021-04-06
JP6935632B2 (ja) 2021-09-15
SG11201806361PA (en) 2018-08-30
BR112018015121A2 (pt) 2018-12-11
LT3407902T (lt) 2020-12-28
US10918678B2 (en) 2021-02-16
HUE050810T2 (hu) 2021-01-28
EP3407902A1 (fr) 2018-12-05
AU2017211244B2 (en) 2019-05-16
ES2820338T3 (es) 2021-04-20

Similar Documents

Publication Publication Date Title
FR3046934B1 (fr) Souche de faecalibacterium prausnitzii cncm i-4573 pour le traitement et la prevention d'une inflammation gastro-intestinale
FR24C1017I2 (fr) Utilisations d'antagonistes d'il-13 pour le traitement de la dermatite atopique
EP3496666A4 (en) DEVICES AND METHODS FOR TREATING HEART VALVE INSUFFICIENCIES
EP3630072A4 (en) METHODS AND COMPOSITIONS FOR TREATMENT OF EXCESSIVE Drowsiness
EP3370748A4 (en) THERAPEUTIC MICROBIOTA FOR THE TREATMENT AND / OR PREVENTION OF FOOD ALLERGY
EP3600281A4 (en) COMBINATION THERAPY FOR TREATING OR PREVENTING TUMORS
MA41013B1 (fr) Compositions comprenant des souches bactériennes
EP3452166A4 (en) INTRANASAL STIMULATION FOR THE TREATMENT OF DISEASES OF MEIBOM'S GLANDS AND BLEPHARITIS
EP3337782A4 (en) DIACEREIN OR ITS ANALOGUE FOR INHIBITING THE EXPRESSION OF ASC, NLRP3 AND / OR FOR THE FORMATION OF NLRP3 INFLAMMASOM COMPLEX
EP3390642A4 (en) COMPOSITIONS AND METHODS OF TREATING RETINITIS PIGMENTOSA 18 AND RETINITIS PIGMENTOSA 13
EP3710008A4 (en) RUNX1 INHIBITION FOR THE TREATMENT OF PROLIFERATIVE VITREORETINOPATHY AND DISEASES ASSOCIATED WITH EPITHELIAL-MESENCHYMAL TRANSITION
EP3405191A4 (en) METHOD AND COMPOSITIONS FOR TREATING HYPERHIDROSIS
FR2999191B1 (fr) Souches probiotiques pour le traitement et/ou la prevention de la diarrhee
EP4005579A4 (en) COMPOSITION WITH LACTOBACILLUS REUTERI ATG-F4 FOR THE PREVENTION OR TREATMENT OF MUSCLE DISEASES
EP3331526A4 (en) NICOTIN-DEGREEING ENZYMES FOR THE TREATMENT OF NICOTINE DEPENDENCE AND NICOTINE POISONING
EP3399993A4 (en) METHOD AND COMPOSITIONS FOR PREVENTING AND TREATING DUCHENNE MUSCLE DYSTROPHY
EP3397262A4 (en) COMBINATION OF AN HDAC INHIBITOR AND ANTI-PD-L1 ANTIBODY FOR THE TREATMENT OF EGG CANCER
EP3541379A4 (en) COMPOSITIONS FOR THE TREATMENT OF HYPERTONIA
EP3801478A4 (en) METHODS AND COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF CALCIPHYLAXIA
EP3398614A4 (en) AGENTS FOR PREVENTION AND / OR TREATMENT OF MORBUS ALZHEIMER
EP3288578B8 (en) Compositions for colon cleansing and the treatment of gastrointestinal disorders
EP3294313A4 (en) METHODS RELATING TO THE PREVENTION AND TREATMENT OF DRUG RESISTANCE
MA53545A (fr) Polynucléotides codant pour l'acyl-coa déshydrogénase à très longue chaîne pour le traitement de l'insuffisance en acyl-coa déshydrogénase à très longue chaîne
EP3294339A4 (en) METHOD AND COMPOSITIONS FOR TREATING ARTHRITIS
FR3017536B1 (fr) Compositions pour la prevention et/ou le traitement de pathologies liees a l'alpha-glucosidase

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20170728

PLFP Fee payment

Year of fee payment: 3

CA Change of address

Effective date: 20171221

CD Change of name or company name

Owner name: UNIVERSITE PARIS 6 PIERRE ET MARIE CURIE, FR

Effective date: 20171221

Owner name: ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS, FR

Effective date: 20171221

Owner name: INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE , FR

Effective date: 20171221

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

CA Change of address

Effective date: 20201104

CD Change of name or company name

Owner name: INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULT, FR

Effective date: 20201103

Owner name: UNIVERSITE PARIS 6 PIERRE ET MARIE CURIE, FR

Effective date: 20201103

Owner name: ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS, FR

Effective date: 20201103

Owner name: ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS, FR

Effective date: 20201104

Owner name: UNIVERSITE PARIS 6 PIERRE ET MARIE CURIE, FR

Effective date: 20201104

Owner name: INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULT, FR

Effective date: 20201104

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10